Randomised clinical trials (RCTs) remain the gold standard in evaluating therapeutic interventions, ensuring that treatment effects are not confounded by systematic errors. Central to these trials is ...
Standardizing the strategy in glioblastoma trials to promote success in cell and gene therapy clinical development.
Patient-reported outcomes in clinical trials for multiple myeloma: Where we are. Prevalence of sarcopenia in patients with gastroesophageal and lung malignancies undergoing surgical resection and its ...
We read with interest the Article by Daniel Ma and colleagues in The Lancet Oncology.1 Ma and colleagues should be ...
When considering a sequence of therapy for a patient with metastatic breast cancer, oncologists rely heavily on clinical trial data. Sometimes, however, clinical trial data may not be as reliable as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback